Target intelligence / Profile preview

Potassium voltage-gated channel subfamily C member 3 (Kv3.3) (Kv3.3)

Target
Kv3.3
Molecular classification
Ion channel, Voltage-gated potassium channel
01

Overview

The Potassium voltage-gated channel subfamily C member 3 (Kv3.3) is a transmembrane protein encoded by the KCNC3 gene, playing a critical role in the repolarization of action potentials in high-frequency firing neurons (UniProt: P48548). Predominantly expressed in the cerebellum, particularly in Purkinje cells, and the auditory brainstem, Kv3.3 exhibits unique fast-opening and closing kinetics at relatively positive membrane potentials (NCBI Gene: 3748). These characteristics enable neurons to sustain high-speed signaling essential for motor coordination and sensory processing (PubMed: 23576631). Mutations in the KCNC3 gene are directly linked to Spinocerebellar Ataxia Type 13 (SCA13), a condition marked by progressive cerebellar degeneration and motor impairment (PubMed: 16415881). Therapeutic interest in Kv3.3 focuses on small-molecule modulators, such as positive allosteric modulators (PAMs), which aim to restore normal firing patterns in diseased states (Autifony Therapeutics). While non-selective blockers like 4-aminopyridine and tetraethylammonium interact with the channel, current drug development efforts prioritize selective agents to minimize off-target effects and potential seizure risks.

Other names
KCNC3Shaw-related subfamily member 3SCA13Voltage-gated potassium channel subunit Kv3.3
02

Mechanism of action

Positive allosteric modulation

03

Biological functions

Action potential repolarizationHigh-frequency neuronal firingRegulation of neurotransmitter release
04

Disease associations

Spinocerebellar ataxia type 13Neurodegenerative diseaseMovement disorder
05

Safety considerations

Pro-convulsant activityOff-target effects on other Kv3 channelsMotor impairment
06

Interacting drugs

4-Aminopyridine

4 more in the full profile.

07

Biomarkers

KCNC3 gene mutationCerebellar atrophySARA score

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily C member 3 (Kv3.3) (Kv3.3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily C member 3 (Kv3.3) (Kv3.3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call